Previous Close | 1.1500 |
Open | 1.6100 |
Bid | 1.3000 |
Ask | 1.4000 |
Strike | 20.00 |
Expire Date | 2024-07-19 |
Day's Range | 1.6100 - 1.6500 |
Contract Range | N/A |
Volume | |
Open Interest | 281 |
ALL-REMOTE COMPANY/WILMINGTON, Del., June 10, 2024--Phreesia partners with the National Kidney Foundation and shares new research on early diagnosis and treatment of kidney disease.
Phreesia ( NYSE:PHR ) First Quarter 2025 Results Key Financial Results Revenue: US$101.2m (up 21% from 1Q 2024). Net...
Phreesia (PHR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.